Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
The aims of this research seminar were to bring together a group of established and young scientists from different areas of research (basic and clinical; pulmonology, microbiology, cystic fibrosis (CF), cell biology, immunology, infectious disease, etc.) related to the study of respiratory infections and their role in inflammatory lung diseases and CF. The aim was to cover a wide range of areas, including new developments in the characterisation of respiratory pathogens, host defence, COPD, CF, and asthma research and drug development. A special focus was on translational approaches to encourage interactions of basic and clinical disciplines.
Bacterial infections in COPD S. Sethi (Buffalo, Ny, United States of America)
| |
New pathogens emerging from the animal kingdom: avian flu and beyond H. Klenk (Marburg, Germany)
| |
Evolution of the infectious disease in cystic fibrosis (CF) B. Tummler (Hannover 61, Germany)
| |
Neutrophils in CF lung disease D. Hartl (New Haven, Ct, United States of America)
| |
Airway mucins in health and disease D. Thornton (Manchester, United Kingdom)
| |
Antimicrobial peptides P. Hiemstra (Leiden, The Netherlands)
| |
How cultured epithelial cells from asthma and COPD patients deal with pathogens: defective anti-rhinovirus responses in asthma D. Davies (Southampton, United Kingdom)
| |
Respiratory viral infections in COPD T. Wilkinson (Southampton, United Kingdom)
| |
Systemic inflammation in COPD – a role for infection? A. Agusti (Palma De Mallorca, Spain)
| |